Menu
Back to Journals » Drug Design, Development and Therapy » Volume 11
Original Research
N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-L-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,268 | Dovepress* | 11,798+ | 1,977 | 13,775 | |
| PubMed Central* | 470 | 168 | 638 | ||
| Totals | 12,268 | 2,145 | 14,413 | ||
| *Since 17 January 2017 | |||||
View citations on PubMed Central and Google Scholar